Answers are grounded in this paper and cite their sources.
Introduction Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder that remains markedly underdiagnosed, despite international recommendations for systematic screening in all patients with chronic obstructive pulmonary disease (COPD). Strategies to improve adherence to guideline-recommended screening in real-world clinical practice are needed. The objective of our study was to evaluate the impact of a structured clinical audit and feedback program on AATD screening practices in patients with COPD in a real-world, multicenter setting. Methods We conducted a multicenter, before-and-after observational study based on two retrospective clinical audits performed in nine public hospitals in Western Andalusia (Spain). Patients >14 years, with COPD diagnosis were consecutively included. The intervention between audits consisted of audit-based feedback, including an educational meeting and periodic reminders. The primary outcomes were the proportion of patients undergoing serum alpha-1 antitrypsin (AAT) determination and rates of genetic testing. Results A total of 895 medical records were analyzed (452 in Audit 1 and 443 in Audit 2). Serum AAT determination increased significantly from 61.1% in the baseline audit to 71.3% in the re-audit (p = 0.00117), representing an absolute increase of 10.3 percentage points. Genetic testing increased from 3.1% to 5.0%, although this difference did not reach statistical significance. Among patients with AAT < 116 mg/dL, genetic testing increased from 44.0% to 50.0%. Genotype results were available for 33 of 36 patients in whom genetic testing was recommended, with M/Z, M/S, S/S, Z/Z, S/Mmalton, Z/Mmalton, and M/Plowell variants identified in addition to M/M genotypes. In the baseline audit, AAT testing was more frequent among patients followed in specialized COPD clinics. Conclusions A pragmatic clinical audit and feedback strategy was associated with an increase in AATD screening among patients with COPD in routine clinical practice. However, substantial gaps remain in the completion of confirmatory genetic testing.
No takes yet. Share an insight, caveat, or question.
Sanchez et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: